Live
- EO releases TTD employees’ cricket team Jersey
- Priyanka Gandhi leads by 90,000 votes in Wayanad, Cong edges out BJP in Palakkad Assembly seat
- US CDC confirms H5N1 bird flu infection in child in California
- Dispose dump yard garbage in 3 months: TTD EO
- Gold rates in Vijayawada today surges, check the rates on 23 November, 2024
- Gold rates in Hyderabad today surges, check the rates on 23 November, 2024
- Punjab bypolls: Counting of votes begins for four Assembly seats
- Kakani lodges complaint against TDP
- Priyanka Gandhi leads in Wayanad, BJP ahead in Palakkad Assembly seat
- Counting underway for Bengal's 6 Assembly seats, Trinamool leads in three
Researchers developing new therapy to treat Parkinson's disease
Cell replacement may play an increasing role in alleviating the symptoms such as movement problems and memory loss of Parkinsons disease PD, researchers say
New York, Feb 18 :Cell replacement may play an increasing role in alleviating the symptoms such as movement problems and memory loss of Parkinson's disease (PD), researchers say.
The most common PD treatment today is based on enhancing the activity of the nigrostriatal pathway in the brain with dopamine-modulating therapies, thereby increasing striatal dopamine levels and improving motor impairment associated with the disease.
However, this treatment has significant long-term limitations and side effects.
"We are in desperate need of a better way of helping people with PD. It is on the increase worldwide. There is still no cure, and medications only go part way to fully treat incoordination and movement problems," said Claire Henchcliffe, MD, from Weill Cornell Medicine in the US.
Recent strides in stem cell technology mean that quality, consistency, activity, and safety can be assured, and that it is possible to grow essentially unlimited amounts of dopamine-producing nerve cells in the laboratory for transplantation, said a study, published in the Journal of Parkinson's Disease.
"We are moving into a very exciting era for stem cell therapy. The first-generation cells are now being trialed and new advances in stem cell biology and genetic engineering promise even better cells and therapies in the future," said Malin Parmar, postdoctoral candidate from the Lund University in Sweden.
"There is a long road ahead in demonstrating how well stem cell-based reparative therapies will work, and much to understand about what, where, and how to deliver the cells, and to whom," said Parmar.
